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   The work in this thesis is focused on the study the anti-cancer property of 
isothiocyanates. We synthesized new compounds, which has isothiocyanate agent, then 
test whether they can prohibit or kill MDA-MB-231/MCF-7 breast cancer cell. The 
classification of isothiocyanates and the mechanism about why they can be use as anti 
cancer agent are introduced in Chapter 1.  
 
In chapter 2, firstly we used a new IR technique: IR imaging to detect thiocyanate 
and isothiocyanate group in living cell. Since the SCN (2146cm-1) and NCS (2056cm-1) 
have very strong IR absorption in the wavelength range that cell itself has not any 
absorption. That’s why IR imaging can tell whether thiocyanate/isothiocyanate goes in 
to the cell or not. This technique will not harm the cell and is very easy to operate. 
 
Secondly, 5 different amino acids were used to modify 4-isocyanato 
phenylisothiocyanate. According to our results, 4-isocyanato phenylisothiocyanate 
itself has certain ability of prohibit cancer cell growth. After modification with one of 
these amino acids (tyrosine), the anti cancer property was improved greatly. It cannot 
only prohibit the proliferation of cancer cell but also can affect the migration speed and 
adhesion ability. Folic acid has also been used to modify 4-isocyanato 
phenylisothiocyanate. After modification, compare to tyrosine one, linked with folic 
acid seems to have better anti cancer results. The reason maybe is folic acid itself also 
has anti-cancer ability to breast cancer. 
 
 iv
Finally, we synthesized gold nanoparticle, which also contains isothiocyanate 
group. This kind of gold nanoparticles should not only be useful to cancer detection but 











Cancer is the general name for over 100 medical conditions involving 
uncontrolled and dangerous cell growth. It is a complex family of diseases, and 
carcinogenesis - the turning of a normal cell into a cancer cell – is a complex, multistep 
process. In terms of molecular and cell biology, however, cancer may represent a 
relatively small number of diseases caused by similar molecular defects in cell 
function and resulting from similar alterations to a cell’s genes. Ultimately, cancer is a 
disease of abnormal gene expression. 
   This chapter gives basic information about cancer itself and cancer prevention. 
Specially about why isothiocyanates have been shown to inhibit carcinogenesis and 
tumorigenesis and as such are useful chemopreventive agents against the development 
and proliferation of cancers. 
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1.1  Cancer and cruciferous vegetables 
 
   The organs and tissues of the body are made up of cells. Each cell has a nucleus, or 
control center, containing coded instructions called genes. The genes tell the cell what 
type of cell it should be, e.g. skin, bone or blood. The genes also tell the cells when to 
divide and replicate themselves in an orderly and controlled manner and how to repair 
damage done through everyday living. Just as there are hundreds of types of cells; 
there are hundreds of types of cancer, few of which can be treated in the same way. 
When the instructions relating to cell multiplication and dying are wrong, the cell may 
start dividing uncontrollably, and not die when it should. In addition, the cancer may 
not follow the usual instructions that keep cells spaced out properly. Every time the 
cell divides, the "bad" instruction is reproduced, so the out-of-control multiplication 
carries on. As these cells can be multiplying more rapidly than healthy cells, the cancer 
cells can form a growing lump in the body called a tumor or a lesion. 
   Our current understanding of the causes of cancer is incomplete, but it is clear that 
cancer is not caused by an injury, such as a bump or bruise. Although being infected 
with certain viruses may increase the risk of some types of cancer, cancer is not 
contagious. No one can "catch" cancer from another person. Cancer develops gradually 
as a result of a complex mix of factors related to environment, lifestyle, and heredity. 
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Scientists have identified many risk factors that increase the chance of getting cancer. 
They estimate that about 80 percent of all cancers are related to the use of tobacco 
products, to what we eat and drink, or, to a lesser extent, to exposure to radiation or 
cancer-causing agents (carcinogens) in the environment and the workplace. Some 
people are more sensitive than others to factors that can cause cancer. 
   According to the World Cancer Report, cancer rates could further increase by 50% 
to 15 million new cases in the year 2020. In the year 2000, malignant tumours were 
responsible for 12 per cent of the nearly 56 million deaths worldwide from all causes. 
In many countries, more than a quarter of deaths are attributable to cancer. In the year 
2000 alone, 5.3 million men and 4.7 million women developed a malignant tumour and 
altogether 6.2 million died from the disease. The report also revealed that cancer has 
emerged as a major public health problem in developing countries, matching its effect 
in industrialized nations. 
   “An ounce of prevention is worth a pound of cure.” Clearly the best way to cure 
cancer is to prevent it. Choosing a healthy lifestyle and environment can help you 
prevent cancer, such as: 
  1) Avoid smoking, whether it be actual smoking or secondhand smoke.  
2) Practice sun safety.  
3) Eat your fruits and veggies. 
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4) Limit your alcohol intake.  
The observations that certain chemicals, some of them natural dietary constituents 
and some not, can decrease tumorigenesis in animals and, by epidemiologic 
implication, humans as well has led to the idea that the intake of certain chemicals can 
either prevent cancer or slow its progression. Numerous chemicals have now been 
tested in experimental animal studies and a number of clinical trials are ongoing. 1  
Theoretically, prevention of carcinogenesis can be accomplished by blockade of 
the initiation or the promotion-progression phases. Cancer chemopreventive agents can 
be classified as antimutagens/carcinogen blocking agents, antiproliferatives, or 
antioxidants (Table 1.1) 
Numerous purified dietary components have been shown to be mutagenic and are 
considered by many to be chemical initiators of carcinogenesis, 2 while still other 
dietary components such as dietary fat, may act as promoters of carcinogenesis. 3 A 
relationship between aspects of diet and human cancer has been the focus of research 
since the 1930s, and particularly in the last twenty years. Even though much remains to 
be understood about mechanisms, it is now possible to draw consistent conclusions 
regarding the role of diet, obesity, exercise, and alcohol in the etiology of cancer, and 





Table 1.1 Pharmacological and chemical structural classification of promising  
chemopreventive agents1
 
Antimutagens/carcinogen blocking agents 
Phase II metabolic enzyme inducers 
Polyphenols 











Anliinflammalories: See under "Antiproliferatives" 
Anlioxidants 
Phase II metabolic enzyme inducers: Sec under "Antimulagens/carcinogen blocking agents" 
Thiols A/-Acetyl-L-cysteine, S-Allyl-L-cysleine. oltipraz 
  
A number of studies support the hypothesis that a diet high in fat and low in 
carbohydrates, fruits and fruit and vegetable fiber increases the risk of colorectal5 and 
other types of cancer. 6 There are a number of potential cancer-preventive ingredients 
in foods7 that can act at various stages in tumor initiation and promotion. This 
information, as well as additional data on naturally occurring food constituents and 
vitamins, has led to the idea that diet modification can be a way to prevent cancer. 8
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 Table 1.2 Qualitative distributions of major food plant phytochemicals 
 
 1 2 3 4 5 6 7 8 9 10 11 12 13 14
Garlic √      √ √  √     
Green Tea   √ √  √    √     
Soybeans  √ √  √ √  √ √ √     
Cereal grains  √ √ √ √ √  √  √     
Cruciferous √  √ √ √ √ √ √  √ √ √   
Umbelliferous   √  √ √ √ √  √   √ √
Citrus   √ √ √ √ √ √  √     
Solanaceous   √ √ √ √ √ √  √     
Cucurbitaceous   √  √ √ √ √  √     
Licorice Root   √   √  √  √     
Flax Seed   √   √   √ √     
1.Sulfides; 2.Phytates; 3.Flavonoids; 4.Glucarates; 5.Carotenoids; 6.Coumarins; 7.Mono-terpenes; 
8.tri-terpenes; 9.Lignans; 10.Phenolic acids; 11.Indoles; 12.isothiocyanates; 13.Phthalides; 
14.Polyacetylenes. 
 
As examples, there are over 20 studies of lung cancer that have reported on 
vegetables and fruit. Of these, more than 95% of these studies show statistically 
significant lower risks in association with higher consumption of one or more classes 
of vegetables and fruits. The story is similar for stomach, esophagus, mouth and 
pharynx cancer. Even for breast cancer, there is good evidence showing lower risk 
associated with higher consumption.  
   There is a long list of potentially protective compounds that may contribute to a 
reduced risk. A partial list is presented is Table 1.2, and some possible mechanisms are 
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shown in Table 1.3. 
 
Table 1.3. Some possible anticarcinogenic mechanisms of substance in vegetables 
 
Antioxidant effects – relevant both to membrane lipids and DNA 
Effects on cell differentiation 
Induce enzymes that detoxify carcinogens 
Block formation of carcinogens, e. g. nitrosamines 
Alter estrogen metabolism – both agonist and antagonist effects 
Alter colonic milieu (including bacterial flora, bile acid composition, pH, faecal bulk) 
Preserve integrity of intracellular matrices 
Effects on DNA methylation 
Effects on nucleotide pool 
Increase apoptosis of cancer cells 
Decrease proliferation 
Inhibition of topoisomerase II 
 
    Studies specifically evaluating the effect of cruciferous vegetables have shown an 
inverse relationship between intake of cruciferous vegetables and cancer incidence. 9 
One meta-analysis suggests that even as little as 10 g of crucifers/day can have a 
significant effect on risk. 10 These findings have led to a considerable number of 
clinical and bench studies in an effort to understand and capture this cancer 








1.2  Chemical profile of cruciferous vegetables 
 
Epidemiological studies indicating that crucifers are better able to protect against 
cancer than many other fruits or vegetables leads to the logical proposal that 
chemoprevention by cruciferous vegetables is associated with some unique aspect of 
their biochemistry. Consumption of cruciferous vegetables, such as broccoli, cabbage, 
cauliflower, watercress, kale and Brussels sprouts, was shown to be associated with 
decreased risks for cancer in the 1980s.  
 
1.2.1 GS and their bioactive hydrolysis products 
 
Cruciferous vegetables contain a series of relatively unique secondary metabolites 
of amino acids, termed glucosinolates. While gulcosinolates are not considered directly 
bioactive, many glucosinolate hydrolysis products, particularly the isothiocyanates, 
appear to have anticarcinogenic activity. 13 The plant family Cruciferae (also called the 
mustard family or Brassicaceae) includes broccoli, parsnip, brussels sprouts, Chinese 
cabbage, radish, horseradish, wasabi, white mustard, watercress, and cauliflower. 
Crucifers also contain many other bioactive components including flavonoids such as 
quercetin,14 minerals such as selenium (Se),15 S-methyl cysteine sulfoxide, and 
1,2-dithiole-3-thione. 16
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The anti-cancer properties of cruciferous vegetables come from phytochemicals 
called isothiocyanates, which stimulate our body to break down potential carcinogens. 
Sulforaphane, a well-known isothiocyanate, can be found in broccoli and in an even 
more concentrated form in broccoli sprouts. It stimulates the body to produce enzymes 
that detoxify carcinogens. Among men and women aged 50 to 74 in a study from 
Harbor UCLA Medical Center in Torrance, Calif., participants who ate the most 
broccoli (average: 3.7 half-cup cooked servings weekly) were only half as likely to 
develop colorectal cancer as subjects who said they never ate broccoli. 
Several glucosinolates appear common to all Brassica, although their relative 
abundance varies not only across the vegetable subspecies, but also across varieties 
within subspecies, 17 in response to growing conditions. 18 The range of glucosinolate 
contents across a group of 50 varieties of broccoli grown under the same conditions 
varied nearly tenfold from 4.0 to 35.6 μmol/g dry weight. 17  
Upon chopping or crushing the vegetable, or even autolysis of the harvested 
vegetable during storage, glucosinolates come into contact with a hydrolyzing enzyme, 
myrosinase or thioglucoside glucohydrolase (EC. 3.2.3.1.), located away from the 
glucosinolate during the life of the plant. The hydrolysis products are glucose, sulfate 
ions, and an unstable thiono compound (Figure 1.1).19 The unstable thiono 
intermediate can rearrange to form an isothiocyanate, a nitrile, or a thiocyanate, 
 9





Figure 1.1 Bioactivation of glucosinolates. Hydrolysis of glucosinolates by the endogenous  
enzymemyrosinase, to form glucosinolate hydrolysis products: nitriles,  
isothiocyanates, and thiocyanates. 
 
1.2.2 The classification of isothiocyanate glucosinolates 
 
Although about 100 different isothiocyanate glucosinolates have been identified, 
only a few are present frequently in the cruciferous vegetables commonly eaten, 
including 2-propenyl- (allyl-), 3-butenyl-, 3-methylsulfinylpropyl-, 
4-methylsulfinylbutyl- (sulforaphane), 4-pentenyl-, and phenylethyl-isothiocyanates 
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Figure 1.2. Chemical structure of main naturally occuring isothiocyanates (R-N=C=S). 
 
 




The anticarcinogenic properties of isothiocyanates have been attributed to their 
ability to alter detoxification pathways, 20, 21 leading to decreased activation of 
procarcinogens and increased excretion of carcinogens. Clinical studies have shown 
that 500 g of broccoli/day for 12 days significantly increased cytochrome P450 (CYP) 
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1A2-dependent caffeine metabolism, even though it did not alter CYP2E1-dependent 
chlorzoxazone metabolism. A diet containing 300 g of cooked Brussels sprouts/day for 
3 weeks increased serum α-class glutathione transferees 1.4-fold. 22 Together these 
data indicate that dietary crucifers can increase detoxification enzymes in humans. 
Rodent feeding studies confirming this effect of whole cruciferous vegetables23-25 
show that specific detoxification enzymes are upregulated by dietary crucifers. 
 
1.3.2 Inhibition of activation 
 
Isothiocyanates may slow proliferation and increase apoptosis of cancer cells, 
resulting in a retardation of tumor growth. It has been proposed that glucosinolate 
breakdown products may protect against initiation of cancer not only by induction of 
phase II detoxification enzymes, but also by inhibiting CYP-dependent activation of 
precarcinogens.26 The anticarcinogenic action of isothiocyanates against nitrosamines 
has been proposed to be due to inhibition of bioactivation of the nitrosamines, a 
CYP2E1-dependent activity. 27
 
1.3.3 Inhibition of cell proliferation and apoptosis 
 
Another mechanism whereby cancer may be prevented is through a decrease in 
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number, or inhibition of growth, of cells that have been transformed to a malignant 
state. In a separate study using the human undifferentiated colon cancer cell line HT29, 
the parent glucosinolate, glucobrassicin, was shown to have no effect (100 µM), while 
the hydrolysis products diindolyl methane (10 µM) and sulforaphane (20 µM) 
decreased cell viability by approximately 50%.28  
Tumor formation and growth may be controlled through a decrease in cell 
proliferation via arrest of the cell cycle and/or an increase in apoptosis or programmed 
cell death. Sulforaphane arrests human colon cancer cells in G2/M-phase and increases 
expression of cyclin A and B, bax, and cell death by apoptosis. 29
 
 
1.4 Chemoprevention of cancer by isothiocyanates 
 
   The most studied bioactive isothiocyanates(ITC) are allyl-ITC (AITC), 30 
benzyl-ITC (BITC), 31 phenethyl-ITC (PEITC), 32 and sulforaphane (SF). 33,34 More 
than 20 ITCs, the majority of which occur in vegetables, have been shown to inhibit 
tumorigenesis induced by a wide variety of chemical carcinogens in animal models,35, 
36 inhibiting tumorigenesis in the lung, stomach, colon, liver, esophagus, bladder, and 
mammary glands. 35-38
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 1.4.1 Sulforaphane (SFN) 
 
  Sulforaphane is a naturally occurring sulfur-containing isothiocyanate derivative 
that helps to mobilize the human body's natural cancer-fighting resources and reduces 
the risk of developing cancer. 
     Sulforaphane, also known as 4-methylsulfinylbutyl isothiocyanates and 
(-)-1-isothiocyanato-4-(R)-(methylsulfinyl) butane, is a cancer chemopreventive agent 
discovered by Dr. Paul Talalay and his team at the Johns Hopkins University School of 
Medicine in 1992. They revealed three-day-old broccoli sprouts contained 20 to 50 
times sulforaphane than mature broccoli heads in 1997. Sulforaphane belongs to a 
general class of natural products that contain an isothiocyanate moiety. Sulforaphane 
exerts its cancer chemopreventive property via the activation of detoxifying enzymes 
and induction of apoptosis. 
 
                       
 
Fig. 1.3 Structure of sulforaphane 
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 In vitro and in vivo studies have reported that SFN affects many steps of cancer 
development. It can modulate early stages of carcinogenetic process (initiation) or 
affect events, such as apoptosis, cell proliferation, and angiogenesis more specifically 
involved in the promotion and progression phases. It is interesting to note that some 
events, such as apoptosis, are widely involved in the activity of SFN at all different 
stages of the carcinogenetic process. 
Several studies indicate that SFN attenuates the effects of carcinogens via 
inhibition of phase I enzymes and induction of phase II enzymes39. In human 
hepatocytes, SFN decreased mRNA levels of CYP3A4, and this translated to a 
decrease in CYP3A4 activity. 39 In acetone-induced rat liver microsomes, SFN was 
also a competitive inhibitor of CYP2E1, with a Ki of 37.0 - 4.5 mM. 40
SFN also protects DNA from chemical insult SFN is a potent inhibitor of 
genotoxicity induced by compounds acting through different mechanisms. In the 
human mammary epithelial MCF-10F cell line, SFN inhibited DNA adduct formation 
by benzo(a)pyrene and 1,6-dinitropyrene by 63–81% and 30–56%, respectively. 41 It is 
important to note that a significant protection was observed at concentrations as low as 
0.1 mM SFN. In the in vitro micronucleus test, SFN reduced the genotoxicity induced 
by the alkylating agent ethyl methanesulfonate, the aneugen vincristine, the oxidizing 
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agent H2O2, and the alkylating and oxidizing agent mitomycin C, with a 60–75% 
inhibition. 42
The effects of SFN on apoptosis induction were described in several cell models. 
For example, exposure of androgen-dependent LnCaP cells to SFN caused the cells to 
become apoptotic, with activation of caspases and a dose-dependent decrease in DNA 
content. 43 Glioblastoma is the most malignant and prevalent brain tumor that still 
remains incurable. Very recent results demonstrated the ability of SFN to induce 
apoptosis both in a non-tumorigenic and in a tumorigenic malignant glioblastoma cell 
line (T98G and U-87MG, respectively) through the activation of multiple molecular 
mechanisms. 44 SFN was recently identified as a novel histone deacetylase (HDAC) 
inhibitor in human embryonic kidney 293 (HEK293), HCT116 human colon cancer 
cells, 45 and three prostate epithelial cells (BPH-1, LnCaP and PC-3). 46
On the whole, SFN appears as a strong inhibitor of cell proliferation through the 
modulation of several molecular mechanisms. Globally considering the several studies 
reporting the proapoptotic and antiproliferative activity of SFN in multiple cell types, 
the lack of genotoxicity, 47 and its tolerability and safety in humans, 48 SFN can 
potentially act against several types of cancer, and at early, intermediate and late stages 
of the carcinogenetic process. Moreover, SFN is a promising antiangiogenic drug and 
is able to inhibit the metastasis of cancer cells. 
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 1.4.2 Allyl isothiocyanate (AITC)  
 
Allyl isothiocyanate is the chemical compound responsible for the pungent taste 
of mustard, horseradish and wasabi. It is a colorless to pale yellow liquid that is 
slightly soluble in water, but well soluble in most organic solvents. Allyl 
isothiocyanate itself does not occur in the mustard seed. Instead, when ground mustard 
seeds are mixed with water, vinegar, or other liquids or when they are chewed, a 
chemical reaction between the enzyme myrosinase and a glucosinolate known as 
sinigrin from the seeds of black mustard (Brassica nigra) or brown Indian mustard 
(Brassica juncea) leads to the production of allyl isothiocyanate. 
The National Toxicology Program49 has evaluated that allyl isothiocyanate (AITC) 
is carcinogenic to rats. That is, AITC caused transitional-cell papillomas and epithelial 
hyperplasia in the urinary bladders of male rats, and fibrosarcomas in the subcutaneous 
tissue in female rats in two-year bioassay. 49, 50
 
                   
 
Fig 1.4. Structure of AITC. 
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 AITC is an effective, and apparently selective, inducer of cell death in both 
colorectal cancer cells51, 52 and prostate cells. 53 This induction of cell death is 
dose-dependent and has been linked to a block in cell cycle at G2/M in both Hela cells 
and prostate cells.  
Tracy K.Smith et al. have examined the effects of allyl-isothiocyanate (AITC) on 
proliferation and death of colorectal cancer cells. HT-29 colorectal cells were exposed 
to AITC for 24h and the number of adherent and detached cells determined. Evidence 
of apoptosis was also determined. The results show that AITC inhibits proliferation of 
cancer cells by causing mitotic block associated with disruption of α- tubulin in 
manner analogous to a number of other chemother apeutic agents. 54  
Dong Xiao et al. demonstrate that allyl isothiocyanate (AITC), a constituent of 
cruciferous vegetables, significantly inhibits proliferation of cultured PC-3 
(androgen-independent) and LNCaP (androgen-dependent) human prostate cancer cells 
in a dose-dependent manner with an IC50 of ~15±17 mM. 53 On the other hand, survival 
of a normal prostate epithelial cell line (PrEC) was minimally affected by AITC even 
at concentrations that were highly cytotoxic to the prostate cancer cells. Reduced 
proliferation of PC-3 as well as LNCaP cells in the presence of AITC correlated with 
accumulation of cells in G2/M phase and induction of apoptosis. 
 18
Whether these isothiocyanates could cause DNA damage was investigated, using 
32P-labeled DNA fragments obtained from the human p53 tumor suppressor gene and 
the c-Ha-ras-1 protooncogene. 55 Allyl isothiocyanate caused Cu (II)-mediated DNA 
damage and formation of 8-oxo-7, 8- dihydro-29-deoxyguanosine (8-oxodG) more 
strongly than benzyl and phenethyl isothiocyanates. Catalase and bathocuproine, a Cu 
(I)-specific chelator, inhibited Cu(II)-mediated DNA damage by these isothiocyanates, 
suggesting involvement of H2O2 and Cu(I). Isothiocyanates induced DNA damage 
frequently at thymine and cytosine residues in the presence of Cu(II). A UV-visible 
spectroscopic study revealed an association between the generation of superoxide and 
the yield of SH group from isothiocyanates. Furthermore, the yield of 8-oxodG 
formation was correlated with their superoxide-generating ability. Allyl isothiocyanate 
significantly induced 8-oxodG formation in HL-60 cells, but not in H2O2-resistant 
HP100 cells, suggesting the involvement of H2O2 in cellular DNA damage. They 
conclude that oxidative DNA damage may play important roles in carcinogenic 
processes induced by allyl isothiocyanate.
 
1.4.3 Phenethyl isothiocyanate (PEITC) 
 
Phenethyl isothiocyanate (PEITC) is the primary product of enzymatic hydrolysis 
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of gluconasturtiin, a glucosinolate found in many cruciferous vegetables. 
 
        
 
                   Fig1.5 Structure of PEITC 
 
 
The inhibition of carcinogenesis by PEITC is believed to be due to its blocking 
the activation of carcinogens. 56 Previous studies demonstrated that PEITC decreased 
the rate of microsomal oxidation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone 
by a competitive mechanism and by inactivating cytochromes P450. 57
Ke Xu, Paul J. Thornalley58 reported that phenethyl isothiocyanate induced 
apoptosis of human leukaemia HL60 and human myeloblastic leukaemia ML-1 cells in 
vitro. Cytotoxicity was associated with an initial decrease in GSH and GSSG, with a 
concomitant formation of the GSH adduct S-(N-phenethylthiocarbamoyl) glutathione 
inside cells, which was then exported from cells. The cytotoxicity of phenethyl 
isothiocyanate prevented by a high concentration of GSH (15 mM) and delayed by the 
antioxidant and c-Jun N-terminal kinase signalling pathway inhibitor curcumin. GSH 
prevented and curcumin partly prevented the decrease in cellular GSH. These studies 
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show that the cysteinyl thiol group of GSH is an important site of thiocarbamoylation 
by phenethyl isothiocyanate during induction of apoptosis and that this may lead to 
depletion of cellular GSH by efflux of the GSH conjugate. Thiocarbamoylation also 
occurred at other sites. The recent demonstration of a critical role for activation of 
caspase-8 in phenethyl isothiocyanate-induced apoptosis suggests that this 
thiocarbamoylation directly or indirectly leads to functional activation of a cell death 
receptor/adaptor protein complex. 
   Epithelial ovarian cancer has the highest mortality rate among gynecologic cancers. 
PEITC was cytotoxic to OVCAR-3 cells, and inhibited proliferation in a 
dose-dependent fashion (IC50 = 23.2 μM). 59 PEITC induced apoptosis by activating 
caspase-3 and -9, without capsase-8 activation. Anti-apoptotic Bcl-2 levels were 
suppressed while pro-apoptotic Bax levels were enhanced. PEITC suppressed 
activation of Akt, ERK1/2, and the expression of transcription factor c-Myc, while 
simultaneously activating pro-apoptotic p38 and JNK1/2. These findings demonstrate 
that PEITC exhibits cytotoxicity towards OVCAR-3 cells and induces apoptosis via 
caspase-9 and –3 pathways. PEITC inhibits Akt, ERK1/2 survival signaling, and 




 1.4.4 Benzyl isothiocyanate (BITC) 
 
 Benzyl isothiocyanate (BITC) is released in significant concentrations from 
cabbage, radishes, Indian cress, garden cress, and mustard spinach. BITC has been 
shown to potently inhibit the proliferation of cultured cancer cells by inducing 
apoptosis. 60-62 Several pathways involved in BITC-triggered apoptosis have been 
postulated, e.g., a c-Jun N-terminal kinase (JNK)-dependent pathway found in Jurkat 
T-cells, 60 a p53-dependent pathway found in JB6 cells, 62 a Bax, cytochrome 




Fig 1.6 Structure of BITC 
 
BITC and PEITC have also been studied extensively for their role in the 
prevention of lung cancer. PEITC inhibits lung carcinogenesis induced by the 
tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), 
whereas BITC (benzyl isothiocyanate) is ineffective in this regard.63 In turn, BITC 
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effectively inhibits benzo(a)pyrene (BaP)-induced lung tumors in A/J mice, whereas 
PEITC is ineffective. 64
In human pancreatic cancer cells, it has been reported that benzyl isothiocyanate 
(BITC) and sulforaphane (SFN), which are abundantly included in garden cress and 
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 CHAPTER 2: IR SPECTROSCOPY OF 
ISOTHIOCYANATES ON SINGLE CELL 





Numerous epidemiological studies have reported that a high dietary intake of 
cruciferous vegetables (broccoli, cabbage, Brussels sprouts, cauliflower and watercress 
etc.) is associated with a reduction in many human pathologies particularly cancer. 1-3 
An important group of agents that has this property are the organosulfur compounds 
such as isothiocyanates (ITCs), abundant in cruciferous vegetables for which 
consumption has epidemiologically shown an inverse link with breast cancer. 4
In fact, cruciferous vegetables contain glucosinolates, which undergo 
enzymatic cleavage to isothiocyanates (ITCs) and indoles after chopping or chewing of 
the vegetables. 5, 6 Isothiocyanates (ITCs) have been shown to inhibit carcinogenesis 
and tumorigensis and as such are useful chemopreventive agents against the 
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development and proliferation of cancers. It has been reported that several ITCs can 
prevent tumour development in various organs. 7,9  
The primary form of ITC in cancer cell is the reduced glutathione conjugate. A 
number of experimental animal models have proved that this kind of thiol conjugates 
of isothiocyanates are potent cancer chemopreventive agents. They induce 
cytoprotection against carcinogenesis by blocking phase 1 enzymes such as 
cytochrome P450s that metabolize procarcinogens to carcinogens and by inducing 
phase 2 enzymes such as glutathione S-transferases that facilitate the excretion of the 
electrophilic metabolites generated from carcinogen metabolism.10-12
Fourier transform infrared (FT-IR) microspectroscopy of cells and tissues 
provides an immense amount of structural information. In the past 5 years, a number of 
research groups started a series of projects and tested the applicability of the 
spectroscopic technique to characterize tissue specimens.13-17 The IR imaging 
methodology provides spatially resolved structural and compositional information on 
the histological specimens and, in combination with computer based multivariate 
image reassembling techniques, opens wide perspectives for routine use in the clinical 
environment. 
IR spectra of more complex biological specimens such as microorganisms or 
tissues represent the superposition of all infrared-active vibrational modes of the 
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various molecules present in the sample. Therefore, IR spectroscopy provides 
information about the chemical constituents (proteins, lipids, nucleic acids, 
polysaccharides, etc.) of the probed material and their molecular structure (Table 2.1). 
When applied to intact microbial cells the FT-IR technique provides spectral 
fingerprints of the complex biological structures under investigation. 18, 19
 
Table 2.1 Frequencies and assignments of absorption peaks found in the IR spectra of 
cells and cell fractions 
 
3300               N–H stretching, amide linkage 
2920               CH2 antisymmetric stretch 
2850               CH2 symmetric stretch 
1737               >C=O (ester) stretch 
1690–1620          Amide I 
1570–1530          Amide II 
1468               CH2 symmetric bend (‘‘scissoring’’) 
1455               Various CH2/3 deformation modes (proteins) 
1397               –COO_ symmetric stretch 
1379               CH3 symmetric bend (‘‘umbrella’’) 
1340–1240          Amide III 
1237               O–P=O antisymmetric stretch (PO2_) 
1173               –CO–O–C antisymmetric stretch 
1150               C–O stretch, C–O–H bend (carbohydrates, mucin) 
1083               O–P=O symmetric stretch (PO2_) 
1063               –CO–O–C symmetric stretch 
1050               C–O stretch, (carbohydrates, mucin) 












Part I: FT-IR Spectroscopy on Single Cells in Mapping 
 Mode    
 






         
A                                  B  
 
Fig 2.1.1.  A: Oral mucosa cell under the normal microscope;  
B: Oral mucosa cell under the mapping mode of IR imaging system and 
selected area. 
 
Oral mucosa cells were scratched from the oral mucosa surface, washed twice in 
pure water, and then quickly transferred onto CaF2 windows. Infrared measurements of 
the dry cells were performed in transmission mode using a FT-IR microscope IR scope 
II (Shimadzu, Japan) equipped with a single MCT detector element and linked to a 
FT-IR spectrometer. The CaF2 windows were placed on the stage of the image system. 
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Under the mapping mode, a single cell was chosen and a small area selected. After that, 
the system was switched to IR mode allowing for the IR beam to pass through this 
selected area of cell in order to record the IR spectrum. This spectrum (Fig 2.1.2) fits 
well with the literature. 
From the figure, there is no peak between 2000cm-1and 2800 cm-1. Based on that, 
if the drug the cell takes in has IR absorption in this region, we can use IR imaging 
system to detect and calculate its concentration. Since the isothiocyanate group has a 
very strong IR absorption at around 2060 cm-1, the appearance of such a peak would 
















Fig 2.1.2: IR spectrum of oral mucosa cell.  
1. 3280 cm-1: N-H stretch;  2. 2920 cm-1: aliphatic C-H stretch;  
3. 1652 cm-1: Amide I;     4. 1548 cm-1: Amide II 
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   Synthesis 
 
Undecylenic acid (Fig 2.1.3) was used as the starting material to react with KSCN 
and I2 for the synthesis of a long chain isothiocyanate (Fig.2.1.4). Initially I2 (3.625g, 
0.01427mol) and potassium thiocyanate (1.734, 0.01784mol) were added into 20mL 
chloroform cooled in an ice bath and stirred for 2 hours. The undecylenic acid 
(1.0957g) in 5 mL chloroform was then added into the mixture and stirred in the dark 
under N2 for 24 hours at room temperature. After filtration and separation, the product 





Fig 2.1.3. Structure of undecylenic acid. 
 
I2   +   KSCN   +   undecylenic acid                  product
 Molar ratio   2.4   :   3       1 
Fig 2.1.4. The synthesis procedure of long chain isothiocyanates  
 









Fig. 2.1.5. IR spectrum of the long chain thiocyanate product.  
(2157cm-1 belongs to SCN) 
The isothiocyanate product h contains the oral 
muc
 
 was t en ded into a solution that ad
osa cells for half an hour. A drop of the solution was then placed onto the CaF2 
windows and allowed to dry. The windows were rinsed with deionized water twice to 
attempt to wash out any isothiocyanate molecules adsorbed onto the surface of the oral 
mucosa cell. With the cell completely dried, the windows were placed on the stage of 
the IR microscopic imaging system. The area between the cells was selected as the 
background spectrum. Based on Fig 2.1.6 and compare to that of Fig 2.1.2, two new 
peaks at 2065 cm-1 and 2156 cm-1 can be clearly seen. One of the two peaks 
corresponds well to the isothiocyanate absorption and should correspond to the 










Fig 2.1.6. IR spectrum after adding long chain ITCs. 
 NCS 
Organic and transition metal derivatives of the thiocyanate ion can exist as 
"linkag
Peak assignment: 2156 cm-1 SCN; 2056 cm-1
 
e isomers." In thiocyanates, the organic group or metal is attached to sulfur: 
R−S−C≡N has a S-C single bond and a C-N triple bond. In isothiocyanates, the 
substituent is attached to nitrogen: R−N=C=S has a S-C double bond and a C-N double 
bond. These two isomers can be converted to each other when increase the presure or 
temperature. When we added our product mixture into the cell solution, the conditions 
changing caused isomer convertion: thiocyanate to isothiocyanate. That why we can 
see two peaks not only SCN peak in IR imaging spectrum. 
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 Part II: Amino Acid Modified 4-isocyanato 
Introduction 








prove the solubility by attaching water-soluble groups on these molecules. 
4-isocyanato phenylisothiocyanate (OCN-C6H4-NCS) contains both isothiocyanate 
–N=C=S (ITC) and isocyanato –N=C=O groups. The isocyanato group is more 
reactive than –NCS and can easily react with –OH or –NH2 group. In this part, we have 
used 4-isocyanato phenylisothiocyanate as the starting compound, react with methanol 
and other 5 types of amino acids in order to investigate the anti-cancer properties of 
this series of isothiocyanate derivatives.  
 
 
Fig 2.2.1. Structure of amino acid 





  4-isocyanato phenylisothiocyanate, all the amino acids (L-serine, L-glycine, 
ocyanate can react with the hydroxy group of methanol. 
After
tional groups. In biochemistry, this term refers to alpha-amino acids with the 
general formula NH CHRCOOH. Amino acids are the chemical units or "building 
blocks" of the body that make up proteins. Protein substances make up the muscles, 
tendons, organs, glands, nails, and hair. Growth, repair and maintenance of all cells are 
dependent upon them. Due to their biocompatibility, the five amino acids chosen are: 
L-serine, L-glycine, L-tyrosine, D-tyrosine and tryptophane for reaction with 
4-isocyanato phenylisothiocyanate (OCN-C H -NCS). We hope that after modification, 
these compounds could more easily be absorbed by cancer cells and show more 
anti-cancer effect than 4-isocyanato phenylisothiocyanate itself especially in 








L-tyrosine, D-tyrosine, tryptophane), were purchased from Sigma-Aldrich and used 
without further purification.  
4-isocyanato phenylisothi
 stirring overnight, compound A was obtained. However the isocyanato (NCO) 
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group in 4-isocyanato phenylisothiocyanate would prefer to react with the –NH2 group 
of amino acid20. A simplified synthetic procedure of the products is outlined in 
Fig.2.2.2  
 
CO N N C S +   Amino acid                      Product
 
 
Molar ratio  1          :         1 
D alkaline medium 
   Fig.2.2.2 The 4-isocyanato phenylisothiocyanate derivatization chemistry 
  4-isocyanato phenylisothiocyanate(0.1056g,0.6mmol) was dissolved in 10mL 
THF
issolved in distilled THF    Dissolved in 
 
 
, and then mixed with 5mL aqueous solution of the amino acid (0.6mmol). After 
stirring for several hours at room temperature, the products were separated and purified 
by high-performance liquid chromatography (HPLC) and characterized by IR, 1H 






                               
pound B 
                          




Fig 2.2.3. The struct ducts after modification 
Characterization: 
 
3324, 2085, 1706, 1600, 1542, 1315, 1234, 1068, 833cm-1); 1H 
 + +
Compound B: IR (3280, 2134, 1637, 1588, 1545, 1503, 1228, 831cm-1); 1H NMR 
O
C N N C S
CH3 H
O
Compound A                    Com
                                      
















ures of the pro
 
Compound A: IR (
NMR δ=7.49, 7.22, 3.74 ppm; MS: m/z: 208 [M] , 209 [M+H]
N
O











δ=7.71, 7.68, 6.30, 5.73, 5.19, 3.96, 3.84 ppm; MS m/z: 356 [M-H]+ 357[M]+
9,3.22,3.12ppm; MS m/z: 310[M]+
MDA-MB-231 breast cancer cells were grown in DMEM (Dulbecco’s modified 
e’s medium) supplemented with 10% foetal bovine serum and 1% antibiotic. 
MCF
Compound C: IR (3297, 2129, 1736, 1638, 1590, 1545, 1503, 1229, 829cm-1); 1H 
NMR δ= 7.42, 7.37, 3.75, 3.28ppm; MS m/z: 211[M]+
Compound D: IR (3364,2062,1724,1653,1598,1552,1502,1231,830,); 1H NMR δ=7.52, 
7.31,3.89ppm; MS m/z: 251[M]+
Compound E: IR (3348,2116,1719,1662,1595,1541,1502,1210,1047,832cm-1); 1H 





-7 breast cancer cell line was cultured in the same medium as MDA-MB-231. 
Cells were incubated in 75mm2 plastic culture flasks at 37°C supplemented with 5% 
CO2/95% air. Cells were split 1:4 every 2-3 days. The ITC compounds are dissolved in 
DMSO and then serially diluted in cell culture medium to the desired working 
concentrations immediately prior to the addition to cells. DMSO was added to control 
group to a final concentration (0.1%) identical to that of treated group. 
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Cell proliferation assay (MTS assay) 
 
Cell proliferation is regarded as one of the key mechanisms for cancer prevention. 
21, 22 To establish reliable short-term assays to measure cell proliferation and apoptosis 
seem
 etrazolium) (MTS) 
in gr
with 5, 10, 20, 40 or 80 µM of the compounds dissolved in 
DMS
s to be a great benefit for studies of cancer chemoprevention.  
The assay based on the reduction of the tetrazolium salt (3 - (4, 5 - dimethylthiazo 
l - 2-yl) – 5 - (3 - carboxymethoxyphenyl) – 2 - (4 –sulfonyl) - 2H –t
owing cells to produce formazon product presumably accomplished by NADPH or 
NADH produced by dehydrogenase enzymes, is a rapid colorimetric assay to measure 
cellular proliferation and cytotoxicity. 23 We have examined the potential activities of a 
variety of chemopreventive agents to decrease cell proliferation in MTS assay using 
human breast cancer cells. 
Twenty thousand cells were trypsinized and seeded per well in 96-wells plate. The 
medium was supplemented 
O and the cells were incubated for a further 5 days before addition of the MTS 
substrate. Control cultures were cultured without compounds treatment but only 
DMSO (0.1%). Absorbance (490 nm) was determined after 4 h incubation at 37°C with 
MTS. According to the results from cell proliferation, a minimal dose with 
proliferation-inhibiting effect of each compound was determined. 
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 Determination of cell number 
 
8 and 24h after exposure to our ITCs compounds, adherent cells and those that 
had detached from the flask surface were harvested separately. The incubation medium 
was 
 
96-well plate was firstly coated with fibronectin or collagen solution (100µL/well) 
over ight. The coating solution was sucked out before adding 100µL/well 1% BSA for 
bloc
centrifuged and the number of detached cells per flask assessed after 
re-suspending the cell pellet in known volume of PBS. The adherent population was 
removed by trypsinization (0.25% trypsin; 0.02%EDTA in PBS,), centrifuged after 
re-suspending the cell pellet in a known volume of PBS. The cell numbers were then 




king. The plate was placed at 4°C overnight. The BSA solution was then removed 
and dried in the hood. Then the cells were trypsinized and seeded in the plate at a 
density of 1×105 per well, in the absence or presence of compound B (15µM). After 
incubating at 37°C for 1 hour, the wells were washed carefully with 1×PBS before 
adding MTS solution. They were further incubated for 4 hours before the absorbance at 
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The cells were trypsinized and seeded in 6-wells plate at a density of 5×105 
er confluences, the medium was sucked out. A tip was used to draw a 
line at 
Transmission Electron Microscope  
The cells were trypsinized and seeded in a 8-chamber plate at a density of 5000 
 chamber before being incubated for 24 hours. Then they were treated with the 
isoth
cells per mL. Aft
the center of each well immediately and the width of these gaps was ascertained 
to remain almost the same. Then it was washed with 1×PBS twice to remove all the 
unattached cells.  The medium supplemented ITCs (15µM) were added to the treated 
group while DMSO (0.1%) was added to the control group. Both were incubated for 12 
hours at 37°C. The cells were observed under the inverted microscope and the cell 




iocyanate compound. After 12 hours of incubation, the cells were removed and 
examined following the protocol for EM sample preparation.  
        1. Fix cells with 2.5%GA in phosphate buffer (pH 7.2-7.4) 
2. Wash with PB 3 times (3×5mins) 
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3. Osmicate (1% Osmium tetroxide in PB) for 45mins. 
4. Wash with PB 3 times (3×5 mins) 
5. Dehydrate through a ascending ethanol series at RT:  
         
         
        
es) 
               nol: araldite   (1 : 4)  30 mins  
ins at 40 deg.C 
 
g C for 24hr. 




    25% ethanol        2 mins 
    50% ethanol         4 mins   
             75% ethanol         4 mins 
             95% ethanol        4 mins 
             100% ethanol       4 mins (3 tim
6. Infiltration: 
             100% ethanol: araldite    (1 : 1) 10 mins 
     100% etha
          1st change of pure araldite 10 mins RT and 30m
           2nd change of pure araldite 30 mins at 45 deg.C
           3rd change of pure araldite 30 mins at 50deg.C 
7. Embed in fresh araldite and polymerise at 60 de
8. Cut with Ultra Microtome (Leica Ultracut UCT
samples were viewed in CM120 (FEI) microscope. 
cal analysis 
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Results and statistical analyses were performed either by a student’s t-test or by 
y–Kramer Comparisons Test using PrismGraphPad 




e previously been found to be potent inhibitors of breast 
cancer cell proliferation. In the present study, the abilities of 4-isocyanatophenyl 
isothiocyanate itself, its derivatives with methanol and amino acids to inhibit cell 
proliferation were compared using MTS proliferation assays.  
50 231 cell proliferation 
measured using the MTS proliferation assays 
 
oneway ANOVA followed by Tuke
2.2.3 Results and discussion 
Cell proliferation assay 
A number of ITCs hav
 
 
Table 2.2.1. Comparison of EC  values for inhibition of MDA-MB-
                S        A          B        C         D         E 
EC50 (µM)     15.74       n.d.       7.48       n.d.       n.d.       62.7 
n.d., not determined 
 
For this purpose, MDA-MB-231 cells were plated at 2000 cells/well and cultured 
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in th
hows a pretty good 
abili
 
e presence of the starting compound and compounds A-E. EC50 values for 
compounds A-E were compared using MTS assays (Table 2.2.1). 
The precursor 4-isocyanato phenylisothiocyanate already s
ty to prevent the proliferation of cancer cell. The effect concentration of 50% 
value is 15.74µM. Some of its derivatives' EC50 (compounds A, C and D) have not 
been determined, as their effects on cancer cells are very slight. Even at very high 
concentration, they cannot kill up to 50% MDA-MB-231 breast cancer cells. Although 
EC50 value of the compound E has been measured, it is much higher at 62.70µM. That 
means the modification did not improve the prohibiting ability. For compound B 
(which is the modification with L-tyrosine), the drug molecules could get into the cell 
easily and prevent the growth of cancer cells successfully. After modification, its EC50 
value decreases from 15.74 to 7.48µM, almost half of the original value. Hence only B 
was used in the following experiments. Representative graphs illustrating the 
inhibition of cell proliferation as determined by the MTS assays are shown in Fig. 
2.2.4 
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for (a) 4-isocynatophenyl isothiocyanate  (b-f) compound A- E. Absorbance value is 
linearly related to the cell numbers which still alive. 
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Fig. 2.2.5. Cell proliferation assay for MCF-7 
 
We have also used MCF-7, another human breast cancer cell line, to do the same 
proliferation assay. For MCF-7, the EC50 value is 19.43uM, which is higher than the 
MDA-MB-231 value (7.48µM). The results show that compound B is not only 
prohibiting the proliferation of MDA-MB-231, but also has very good potential to 
prevent MCF-7 cancer cell’s proliferation. Based on that, compound B is considered to 
be very effective on both breast cancer cell lines. 
ermination of cell number 
Charging the MDA-MB-231 cells with compound B (15 µM) resulted in the 
shedding of cells from the surface of the flask into the surrounding medium 24 h after 





inverted microscope revealed that adherent cells treated with ITC were beginning to 
deform and form more spherical structures from the original elongated shapes.  
At 24 h, results from 3 separate experiments showed that under control conditions, 
3.6% of cells became detached from flask surface, whereas treatment with ITC resulted 
in an average of 30.8% of cells becoming detached. When the ratio of detached cells to 
total cell number in treated flasks was expressed relative to the ratio in control flasks, 
it was apparent that an average of 17.3 times as many cells became detached in 
response to ITC treatment for 24h. Over the same period the number of adherent cells 




Because cell adhesion affects cell differentiation and proliferation, biologists and 
chemists usually evaluate cell physiology by analysis of the cell adhesion phenomena. 
After cells have been seeded on the substrate, the extracellular matrix (ECM) proteins 
and their amino acid components such as fibronectin and collagen can bind with the 
membrane proteins by covalent bonds. Only then cell spreading will occur. Cells start 
to express their functions such as proliferation, differentiation and so on upon 
spreading. 
Two different kinds of adhesion proteins were chosen as coating materials: 
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collagen and fibronectin in order to test the effects of compound B to MDA-MB-231 
human breast cell adhesion ability. From Fig. 2.6, when the substrate was coated with 
collagen and after washing twice with PBS, there are still 94.3% of cell attached to the 
coating substrate in the treated group. That means only 5.7% of cells were washed out. 
At the same time, for fibronectin coating group, after washing with PBS, nearly half 
(43.3%) of the cells could no longer be attached firmly on the coating substrate 
compared to the control group,. Compound B is effective in discouraging cell adhesion 
by preventing the fibronectin protein to form covalent bonds with the cell membranes. 
As a result, the cells may not seed on the substrate properly. Then they will not proceed 




























Fig.2.2.6. Cell adhesion:  






Understanding cell migration is also an important part of cancer research. This is 
















Fig. 2.2.7. a (control) and b (treated) are taken at initial hour(0h).   Fig.2.2.8. migration distance* 
c (control) and d (treated) are taken at 16 hours later 
 
The images (a: control) and (b: treated with compound B at a concentration of 
15µM) are taken at 0 h. After incubation for 16 hours, the images were taken again 
where picture c is of the control group and d is of the treated group. Comparing c and d, 
there appears to be a big difference between them where in the control group (c), the 
migration of the cell is very fast with the gap almost filled. Only a narrow channel is 
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left between the two-separated sides of the cells. In the treated group, although the gap 
distance also decreased compared to the initial distance, the movement of the cell was 
obviously slower than the control group. The gap width is at least two times that of the 
control group. This shows that compound B is effective in inhibiting the migration of 
the breast cancer cells. 
Fig 2.2.8 shows the statistical data of the cell migration distance of both control 
and treated groups after 16 hours of treatment. On average, the cells in the control 
group moved 174.5µm within 16 hours, whereas the cells supplemented with 
compound B moved only 95.7µM. In other words, the cancer cell migration distance is 
54.8% of the control group. Compound B potentially rendered the cancer cell 
migration nearly 2 times slower.  
 
Optical isomers of tyrosine 
 
The amino acids used so far are of the L-configuration. However amino acids 
can occur in two possible optical isomers, D and L although D-amino acids rarely exist 
in nature except in polypeptide antibiotics.  
We also tested the optical structure of amino acids as to whether they can affect 
the anti-cancer property on breast cancer lines. D-tyrosine was used to react with 
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4-isocyanatophenyl isothiocyanate and from the cell proliferation (MTS) results 
comparison (Fig.2.2.9), the EC50 value of D-tyrosine product was found to be 9.4uM. 
Since the EC50 for the L-tyrosine derivative is 8.6uM, this does not constitute a 




Fig 2.2.9. Optical isomer compare. L: reacted with L-tyrosine; D: reacted with D-tyrosine 
 
Transmission electron microscopy imaging  
 
We have used TEM imaging to examine the cell condition upon treatment with 
the isothiocyanate compounds. The three images (A) shown in Fig.2.2.10 belong to the 




















y distinguish each part of the cell structure: nucleus, cytoplasm, mitochondrion, 
endoplasmic reticulum and cell membrane. According to the shape of these cells, 0.1% 
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DMSO did not effect the cell growth as they appear normal and healthy. The B pictures 
however show that the cells treated with 10uM of compound B are very different from 
the control group. When the cell took in these molecules, it will attempt to enclose 
them in order to protect the cell from contamination. These molecules will be 
decomposed and digested by the cell. After these unwanted components were removed, 
a vacancy appears to be left in the cell. As the cell took in more of these molecules, the 










Fig.2.2.10. EM picture of cancer cell after 20 hours treatment with 10uM compound B 
 




can be seen at the f
than the control group. The cell still looks alive and healthy. Cell (b) is in the second 
stage
We have synthesized a series of isothiocyanate derivatives compound to 
investigate the effects of organic isothiocyanate for human breast cancer cell. When the 
ompound is linked to the tyrosine amino acid, the anti-cancer properties become twice 
as pote
irst stage where the numbers of tiny cavities are only a little more 
 where the cavities became more numerous. However the cell nucleus remains 
unaffected. Cell (c) is in the third level of this procedure. The cell used up all its 
energy to digest and remove the unwanted component and thus has no more energy and 
nutrition to grow on. It is dying and eventually the cell will be broken into fragments 





nt when compared to the parent molecule. Both L and D-tyrosine derivatives are 
equally effective. Studies on the process show that upon cell migration inhibition, 
loosening of cell adhesion and creation of cavities within the cell which eventually 





Part III: Other Modifications 
 
3.1. Folic acid derivatives 
Folic acid and folate (the anion form) are forms of the water-soluble Vitamin B9. 
d can also be taken as supplements. Folic acid is 
onsidered an essential nutrient because it cannot be made by the human body. It is 
requ





These occur naturally in food an
c
ired by the body for essential processes. Folic acid helps the body to create and 
maintain DNA and RNA, which are the building blocks of all life. We require folic 
acid to properly form red blood cells and for our bodies to metabolize protein for 
energy. 
Folic acid along with other B vitamins is an important part of the DNA and RNA 
replication process. Every now and then there can be a mistake in the replication of a 
DNA strand, whi
 those mistakes and even prevent them so that there will always be healthy cells 
from the beginning. In fact this is part of why folic acid is so important to take just 
before and during pregnancy to help prevent birth defects such as Spina Bifida, cleft 
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palate, cleft lip, and other neural tube defects. 
Some evidences associate low blood levels of folate with a greater risk of 
cancer.24 Folate is involved in the synthesis, repair, and functioning of DNA, our 
genetic map, and a deficiency of folate may result in DNA damage that may lead to 
canc




er.25 Several studies have associated diets low in folate with increased risk of 
breast, pancreatic, and colon cancer.26  
From the structure of folic acid, we found that it also contains NH2 group which 
can react with the NCO group of 4-isocyanato phenylisothiocyanate. So we have 
reacted 4-isocyanato phenylisothiocyan



















Experiment and results 
 
Dissolved 0.2205g (0.5mmol) folic acid in 5mL alkaline solution. Added the THF 
sol o phenylisothiocyanate (0.088g, 0.5mmol) into it. Put 
this mixture in dark, N2 protected and stirred for at least 24 hours with gentle heated 
(abo
 
ution (5mL) of 4-isocyanat
ut 45 degree). After filtration and separation, a product was obtained (compound 
F). From the IR spectrum, the very strong absorption at 2046cm-1 obviously belongs to 
the NCS group but the NCO group has disappeared, indicating a reaction with folic 
acid. Unfortunately we were unable to provide more information regarding the 
structure of the molecule as to which amine group the NCO reacted with. Nevertheless 











 Compound F: IR (3248, 2109, 1662, 1545, 1507, 1210, 1042, 837cm-1); MS m/z: 
617[M]; 616 [M+] 
 
TS assay 
  We continue to use MTS assay to test the anti-cancer ability of compound F. MTS 
ll proliferation assay. The principles and protocol regarding this assay has 
lready been introduced in Part II. From Fig 2.3.3, we can see that compound F is very 





assay is a ce
a
effective in killing breast cancer cells. When the concentration was not more than 1µM, 
there is no effect on MDA-MB-231 breast cancer cell. But when we increased the 
concentration to 5µM, it almost killed all cancer cells in the plate. Based on that, we 
calculated the EC50 value of this compound to be about 3.8µM, much smaller than that 














        












A                                 B  
F.P.
















  Fig 2.3.3 MTS assay data. (A) Folic acid itself; (B) 4-isocyanato 




art II cell adhesion 
experiment part. The two figures in Fig 2.3.4 show the results of cell adhesion upon 
   The protocol in cell adhesion is the same as the protocol in P
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treatment by compound F. Two different kinds of adhesion proteins were chosen as 
coating materials, namely, collagen and fibronectin, to test the effect of the compound 
on cell adhesion.  
For the collagen test, there were still 72.8% of cell attached to the coating 
substrate in the treated group while only nearly half (46.9%) of the cells can still 
attached firmly on the coating substrate of fibronectin. Thus compound F can prevent 
cell adhesion protein fibronectin to form covalent bond with cell membrane effectively. 
As a result, if the cells cannot seed on the substrate properly, they will not proceed to 


























                A                                 B 
 
Fig 2.3.4. Cell adhesion results. A is Collagen and B is fibronectin 
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Cell migration  
 
The protocol in cell migration part for compound F is the same as the protocol in 
Part II cell migration experiment part. Fig 2.3.5 is the data on cell migration distance 
of both the control and treated group after 16 hours of treatment. On average the cells 
in the control group moved 186.5µm within 16 hours, whereas the cells supplemented 
with compound B moved only 86.4µm. The cancer cell migration distance is 46.3% of 
the control one, indicating the compound discourages MDA-MB-231 breast cancer cell 

















Fig. 2.3.5. Cell migration results. 
 
Comparison between compounds B and F 
 
 Both compound B and compound F can kill MDA-MB-231 effectively. Since the 
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EC50 value is a very important value for e aluating a cancer drug, we compare the 
va h one is better.  
 MDA-MB-231 MCF-12A 
v
lues for these two compounds to find out whic
 
Table 2.3.1 Comparison of EC50 values for compounds B and F 
 
B (µM) 7.8 3.2 
F (µM) 3.8 2.4 
 
From Table 2.3.1, EC50  is 7.8µM for MDA-M ast cancer 
cell. ormal cell MCF-12A, the value is only 3.2µM, less tha lf of the dose 
for t r cell. When the drug concentration is 3.2µM, 50% n l cell will be 
killed and at the same time, around 40% cancer cell also were killed. For compound F, 
EC50 for breast cancer cell is 3.8µM and for normal cell is 2.4µM. When the drug 
concentration is 2.4µM, 50% normal cell will be killed, but around 60% of breast 
cancer cells are killed. We conclude that compound F is slightly more effective in 
killing cancer cells relative to normal cells and also does it at a lower concentration. 
 
2.3.2. Sodium citrate diamine and pyruvic acid derivatives 
H 
 of compound B B-231 bre
 But for n n ha
he cance orma
 
Besides folic acid, we have also tried other molecules that contain NH2 or O
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group so that they can react with the NCO group easily. Sodium citrate, 
pounds were 
cancer activities.  
Sodium citrate possesses a saline, mildly tart, flavor. For this reason, citrates of 
certain alkaline and alkaline Earth metals (e.g. sodium and calcium citrates) are 
commonly known as sour salt (occasionally citric acid is erroneously termed sour salt). 
We hope that modification can improve the solubility of the isothiocyanate product. 
When the solubility in water is increased, the compound may be able to penetrate 





              3 
Fig 2.3.6 Structures of 1. sodium  2. ethylenediamine and 3. pyruvic acid. 
ethylenediamine and pyruvic acid are three such examples. These com









Ethylenediamine is a colorless to slight yellowish liquid, with an ammonia-like 
odor. It is relatively basic, and is completely miscible in polar solvents such as water 
and ethanol. It is very reactive, r nds with carboxylic acids 
(amid
alcoh




es), fatty acids (imidazoline), nitriles (amidoamines, polyamides, imidazolines), 
ols and glycols (alkylated or cyclic ethyleneamines), alkylhalides and arylhalides 
(substituted amines), carbon disulfide (thiocarbamates), and forms water soluble salts 
with inorganic acids. It has two NH2 group which should react with the NCO group in 
4-isocyanato phenylisothiocyanate.  
Pyruvic acid (CH3COCO2H) is an alpha-keto acid which plays an important role 
in biochemical processes. Pyruvic acid is a key intersection in the network of 
metabolic pathways. Pyruvic acid can be converted to carbohydrates via 
gluconeogenesis, to fatty acids or 
ne and to ethanol. Therefore it unites several key metabolic processes. Pyruvate 
will repair injured mitochondria to kill the tumor. 3-bromopyruvate has been studied 






Experiment and results 
 
Firstly we use the similar synthesis method to modify 4-isocyanato 
phenylisothiocyanate with sodium citrate, ethylenediamine and pyruvic acid. The 
products were labeled as G, H and I respectively. The NCS groups in their structures 
are all verified by IR spectruoscopy. 
6, 1652,1588, 1503, 1249, 829cm-1); MS m/z: 
265[M-] 
According to the MTS assay data; the products of sodium citrate, diamine and 
pyruvic acid reacted with 4-isocyanato phenylisothiocyanate are not anti-cancer 
effective at all.  
 
 
Compound G: IR (3298, 2091, 1706, 1607, 1239, 1068, 841cm-1); MS: m/z: 435 [M-] 
Compound H: IR (3280, 2112, 1580, 1503, 1234, 836cm-1); MS m/z: 236 [M] 235[M+] 















     












              A                                  B 
 











Fig 2.3.7  A: compound G; B: compound H; C. compound I 
 
2.3.3. Gold nanoparticles 
 
In an earlier study we know that gold n bound to malignant 
cells, making cancer detection easier. Many cancer cells have a protein, known as 
anoparticles could be 
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epidermal growth factor receptor (EGFR), distributed widely on the outside of their 
lthy cells typically do not produce much of this protein. 
ttaching gold nanoparticles to an antibody for EGFR (anti-EGFR), the researchers 
were able to get the nanoparticles to specifically attach themselves to the cancer cells. 
If we can link anti-cancer agent to this kind of particle, then it cannot only help to 
detect cancer but also can attack the cancer cell. 
 
Au-MCH nanoparticle synthesis  
 
cell membranes. In contrast, hea
By a





Fig 2.3.8 (a) High magnification TEM image of Au-MCH nanoparticles; (b) TEM 
image showing a close up image (with lattice spacing) of Au-MCH nanoparticles of 
1.5±0.3nm diameter. 
 
Au-MCH nanoparticles were synthesized according to a modified literature 
procedure9. Briefly, tetrachloroaurate trihyd e HAuCl4.3H2O (0.1g, 0.254 mmol) and rat
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excess tetraoctylammonium bromide, (C8H17)4N Br  (0.56g, 1.03 mmol) were 
dissolved in a water/toluene mixture (30 mL/50 mL). When the organic phase turned 
+ -
den, MCH (0.136 g, 1.01mmol) was added and the solution was stirred vigorously 
for 10 min until the organic phase became white and cloudy. Aqueous sodium 
borohydride (96mg, 2.54 mmol, dissolved in 5mL of water immediately prior to use) 
was rapidly added and the organic phase immediately turned dark brownish. Dark 
precipitate appeared in toluene. This solution was stirred for another half an hour 
before the resulting solid was washed with a series of solvents (toluene, acetone, 
hexane, acetone/water (5:1)) to remove the phase transfer catalyst, byproducts and 
unreacted starting materials. After purification, the yield is 34.7% (17mg of purified 
Au-MCH nanoparticles). 
 
Linked NCS to Au-MCH nano particles 
mol NCS-C6H4-NCO was stirred for 48 to 72 hours at room 
temperature with the resulting product precipitated upon addition of excess toluene. 
Th , washed with toluene to remove unreacted 
CS-Ph-NCO and stored in a vacuum desiccator. 
gol
 
For the reaction of Au-MCH with NCS-C6H4-NCO, a THF solution containing 
50mg Au-MCH and 2.33m




    
From Fig 2.3.9, apparently Au-MCH itself has good ability to prohibit the 
proliferation of MDA-MB-231 breast cancer cell. The EC50 value is about 8.3uM. Fig 
2.3.10 shows that after linking NCS group to this gold nanoparticle, EC50 value 
M) has not decreased very much. (7.9µ
 
 

























Fig 2.3.10. MTS assay results after modification with isothiocyanates 
    
2.3.4. Conclusion: 
 
We have found that apart from the tyrosine derivative of isothiocyanate, its folate 
derivative and gold nanoparticles functionalized with mercaptohexanol also serve as 
potent anti-cancer agents with even lower EC50 values. Other derivatives attempted 
ere did not seem to affect the cancer cells to significant extent. In further work, we 
ho
h
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